Concord Drugs Limited (CONCORD.BO)
- Previous Close
32.67 - Open
32.60 - Bid 31.55 x --
- Ask 32.00 x --
- Day's Range
31.25 - 33.29 - 52 Week Range
26.10 - 41.00 - Volume
3,097 - Avg. Volume
7,071 - Market Cap (intraday)
318M - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
93.53 - EPS (TTM)
0.34 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Concord Drugs Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers tissue bio-adhesive products. The company also provides ready-to-fill pellets and multiple unit pellets system; drugs in the form of tablets, capsules, small volume parenterals, dry powders, syrups and suspension, and dry syrups; and hand sanitizers. Concord Drugs Limited was incorporated in 1995 and is based in Hyderabad, India.
concorddrugs.in--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: CONCORD.BO
View MorePerformance Overview: CONCORD.BO
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CONCORD.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CONCORD.BO
View MoreValuation Measures
Market Cap
318.00M
Enterprise Value
486.46M
Trailing P/E
93.53
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.69
Price/Book (mrq)
0.93
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
11.73
Financial Highlights
Profitability and Income Statement
Profit Margin
0.74%
Return on Assets (ttm)
2.73%
Return on Equity (ttm)
0.99%
Revenue (ttm)
452.45M
Net Income Avi to Common (ttm)
3.36M
Diluted EPS (ttm)
0.34
Balance Sheet and Cash Flow
Total Cash (mrq)
2.25M
Total Debt/Equity (mrq)
56.41%
Levered Free Cash Flow (ttm)
72.16M